Trials / Conditions / Blasts More Than 5 Percent of Bone Marrow Nucleated Cells
Blasts More Than 5 Percent of Bone Marrow Nucleated Cells
4 registered clinical trials studyying Blasts More Than 5 Percent of Bone Marrow Nucleated Cells — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Vyxeos for Re-induction Treatment of Acute Myeloid Leukemia Patients With Persistent Disease After Induction NCT04049539 | Ohio State University Comprehensive Cancer Center | Phase 1 / Phase 2 |
| Recruiting | Ruxolitinib in Treating Patients With Hypereosinophilic Syndrome or Primary Eosinophilic Disorders NCT03801434 | William Shomali | Phase 2 |
| Recruiting | CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomo NCT03896269 | M.D. Anderson Cancer Center | Phase 1 |
| Completed | Phase I/II Study of Bosutinib in Combination With Inotuzumab Ozogamicin in CD22-positive PC Positive ALL and C NCT02311998 | M.D. Anderson Cancer Center | Phase 1 / Phase 2 |